LivaNova to Host Conference Call for Fourth Quarter and Full-Year 2018 Results

Livanova PLCA (NASDAQ:LIVN), a market-leading medical technology company,
will host a conference call to discuss its fourth quarter and full-year
2018 results onA Wednesday, Feb. 27, 2019 atA 1 p.m. LondonA time (8 a.m.
Eastern Standard Time). The Company will release its fourth quarter and
full-year 2018 results prior to the call.

A live webcast of the conference call will be available on the Investor
Relations section of LivaNovaa??s website atA
To listen to the conference call by telephone, dial 844-601-5111 (if
dialing from within the U.S.) or 647-253-8650 (if dialing from outside
the U.S.). The conference ID is 9270818. Listeners should log on
approximately 10 minutes in advance to ensure proper setup to receive
the webcast. A replay will be available on theA LivaNovaA website for 90
days following the call.

About LivaNova

LivaNova PLCA is a global medical technology company built on nearly five
decades of experience and a relentless commitment to improve the lives
of patients around the world. LivaNovaa??s advanced technologies and
breakthrough treatments provide meaningful solutions for the benefit of
patients, healthcare professionals and healthcare systems. Headquartered
inA London,A LivaNovaA has a presence in more than 100 countries worldwide.
The Company currently employs approximately 4,000 employees.
LivaNovaA operates as two businesses: Cardiovascular and Neuromodulation,
with operating headquarters in Mirandola (Italy) andA HoustonA (U.S.),

For more information, please visit

Safe Harbor Statement

This news release contains forward-looking statements within the meaning
of Section 27A of the United States Securities Act of 1933, as amended,
and Section 21E of the United States Securities Exchange Act of 1934, as
amended. Forward-looking statements are not historical facts but are
based on certain assumptions of management and describe LivaNovaa??s
future plans, strategies and expectations. Forward-looking statements
can generally be identified by the use of forward-looking terminology,
including, but not limited to, "may," "could,a?? "seek,a?? "guidance,a??
"predict,a?? "potential,a?? "likely,a?? "believe," "will," "expect,"
"anticipate," "estimate," "plan," "intend," "forecast," or variations of
these terms and similar expressions, or the negative of these terms or
similar expressions. Forward-looking statements contained in this news
release are based on information presently available to LivaNova and
assumptions that LivaNova believes to be reasonable, but are inherently
uncertain. As a result, LivaNovaa??s actual results, performance or
achievements may differ materially from those expressed or implied by
these forward-looking statements, which are not guarantees of future
performance or actions that may be taken by LivaNova and involve known
and unknown risks, uncertainties and other factors that are, in some
cases, beyond LivaNovaa??s control. You should carefully consider the
risks and uncertainties that affect LivaNova, including those described
in the "Risk Factorsa?? section of LivaNovaa??s Annual Reports on Form 10-K,
Quarterly Reports on Form 10-Q, Current Reports on Form 8-K and other
documents filed from time to time with the United States Securities and
Exchange Commission.
See also:
Leave a comment
  • Latest
  • Read
  • Commented
Calendar Content
«    Май 2022    »